MPEP § 2413.01 — Parts of the “Sequence Listing XML” (Annotated Rules)
§2413.01 Parts of the “Sequence Listing XML”
This page consolidates and annotates all enforceable requirements under MPEP § 2413.01, including statutory authority, regulatory rules, examiner guidance, and practice notes. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.
Parts of the “Sequence Listing XML”
This section addresses Parts of the “Sequence Listing XML”.
Key Rules
Sequence Listing Content
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
Sequence Listing Format
The constituent parts of the “Sequence Listing XML” are identified in multiple paragraphs of WIPO Standard ST.26 and have been specifically incorporated into the USPTO rules of practice at 37 CFR 1.839.
Citations
| Primary topic | Citation |
|---|---|
| Sequence Listing Content | 37 CFR § 1.831(b) |
| Sequence Listing Format | 37 CFR § 1.839 |
Source Text from USPTO’s MPEP
This is an exact copy of the MPEP from the USPTO. It is here for your reference to see the section in context.
Official MPEP § 2413.01 — Parts of the “Sequence Listing XML”
Source: USPTO2413.01 Parts of the “Sequence Listing XML” [R-01.2024]
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
The constituent parts of the “Sequence Listing XML” are identified in multiple paragraphs of WIPO Standard ST.26 and have been specifically incorporated into the USPTO rules of practice at 37 CFR 1.839.